| Code | 08769 | ||||||||||
| MA number | 21/0481/13-S | ||||||||||
| Product Form: | cps 100x300 mg (blis.(Al/PVC/PVDC) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| Therapeutic Class: | 21 - ANTIEPILEPTICA, ANTICONVULSIVA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 60 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 18.08.1977 |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| Pediatric warnings: | Yes |
| Dokument: |
DHPC_valproate 22 12 2014.pdf
|
| PIL: |
PIL_Convulex cps_10.2022.pdf
|
| SPC: |
SPC_Convulex cps_10.2022.pdf
|
| Dokument: |
DHPC_Valproát_19.02.2024.pdf
|
| Safety feature | Yes |
| Data update: | 17.04.2018 |
